Clinical trials: sponsored by IRCCS San Raffaele
Ischemic Heart Diseases
AI-enhanced Heart MRI for Evaluating Blood Flow
This study will compare the standard MRI protocol with an advanced MRI protocol for the assessment of ischemic heart disease. The goal is to evaluate whether the advanced protocol provides comparable or improved diagnostic…
- Trial name
- NCT07833774
- Testing
- Accelerated advanced MRI sequences protocol
- Volunteers
- 300 people
- Sponsor
- IRCCS San Raffaele
Computed Tomography Angiography, Coronary Artery Disease
Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic Coronary Syndrome
Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide. Coronary computed tomography angiography (CCTA) is recommended as a first-line imaging test in patients with suspected obstructive CAD.
- Trial name
- COST-PCCT-CCS (NCT07831304)
- Testing
- Radomization to undergo CCTA with EID-CT, Randomization to undergo CCTA with PCD-CT
- Where
- Italy
- Volunteers
- 630 people
- Sponsor
- IRCCS San Raffaele
Esophageal Cancer, Esophageal Neoplasms
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI
Evaluate the potential role of PET/MRI as a predictor of esophageal and junctional cancers in response to neoadjuvant chemoradiotherapy (nCRT).
- Trial name
- Escape (NCT04359732)
- Testing
- hybrid PET/MRI
- Where
- Italy
- Volunteers
- 121 people
- Sponsor
- IRCCS San Raffaele
FFR-CT, CT Angiography
Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT
Coronary artery disease (CAD) is the leading cause of mortality and morbidity worldwide. Coronary Computed Tomography angiography (CCTA) gained a pivotal clinical role for excellent sensitivity in rule-out CAD, but has limited…
- Conditions
- FFR-CT, CT Angiography, CT Perfusion, Coronary Arterial Disease (CAD)
- Trial name
- SURE-CT (NCT07544277)
- Where
- 2 sites in Italy
- Volunteers
- 142 people
- Sponsor
- IRCCS San Raffaele
Parkinson's Disease, Parkinsonism
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism
VISMEMO-PD is an observational pilot study aimed at investigating visuospatial memory in reaching space and topographical memory in navigational space in patients with Parkinson's disease and Parkinsonism.
- Conditions
- Parkinson's Disease, Parkinsonism, Multiple System Atrophy, Progressive Supranuclear Palsy
- Trial name
- VISMEMO-PD (NCT07827963)
- Testing
- Multimodal visuospatial and topographical memory assessment
- Where
- 3 sites in Italy
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele Roma
Whole Body Imaging, Prostate
AI Technologies for Enhanced and Celerated High-Field WB-MRI
Single-center, cross-sectional observational study assessing the feasibility of advanced accelerated MRI sequences versus standard ones in terms of image quality, diagnostic reliability, and acquisition time.
- Conditions
- Whole Body Imaging, Prostate, MRI, Lung
- Trial name
- AITECH-MRI (NCT07678320)
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele
Prostate Cancer, Renal Cancer
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
This is a prospective single-center observational study comparing single-port (SP) and multi-port (MP) robot-assisted surgery in adult patients undergoing robot-assisted radical prostatectomy (RARP) or robot-assisted partial…
- Trial name
- NCT07610083
- Where
- Italy
- Volunteers
- 376 people
- Sponsor
- IRCCS San Raffaele
Pancreatitis, Pancreatic Disease
Activation of Biobank Registry for Bilio-pancreatic Diseases
The purpose of establishing the biobank is to create a collection of biological material and clinical data, with a prospective and retrospective mold, in order to investigate the role of genetic predisposition in multifactorial…
- Conditions
- Pancreatitis, Pancreatic Disease, Non-Neoplastic Pancreatic Disorder, Pancreatic Adenocarcinoma
- Trial name
- BIO-PANCREAS (NCT06552078)
- Where
- Italy
- Volunteers
- 2,000 people
- Sponsor
- IRCCS San Raffaele
Pancreas Neoplasm, Cancer of Pancreas
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
The aim of the TAILOR-EUS study (Iconographic Registry of Bilio-Pancreatic Endoscopic Ultrasound Procedures) is to establish a clinical registry comprising images and videos generated during endoscopic procedures conducted for…
- Conditions
- Pancreas Neoplasm, Cancer of Pancreas, Pancreatitis, Neuroendocrine Tumors
- Trial name
- TAILOR-EUS (NCT06344507)
- Where
- Italy
- Volunteers
- 12,000 people
- Sponsor
- IRCCS San Raffaele
Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma (PDAC)
EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer
The EUS-AI-R study is an observational, single-center, two-phase (retrospective-prospective) study designed to develop and validate artificial intelligence (AI) models for predicting chemotherapy response and oncological outcomes…
- Conditions
- Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma (PDAC), Artificial Intelligence (AI), Endoscopic Ultrasound (EUS)
- Trial name
- EUS-AI-R (NCT07803770)
- Testing
- Endoscopic ultrasound (EUS), with or without tissue acquisition (EUS-FNA/FNB), performed according to standard clinical practice. No study-specific intervention is introduced.
- Where
- Italy
- Volunteers
- 700 people
- Sponsor
- IRCCS San Raffaele
Pancreatic Cancer, Biliopancreatic Diseases
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
The GENTLENESS study is a prospective, multicenter, observational registry designed to evaluate the endoscopic management of patients with suspected biliopancreatic and periampullary neoplastic diseases within the Pancreas Units…
- Conditions
- Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
- Trial name
- GENTLENESS (NCT07418164)
- Where
- 13 sites in Italy
- Volunteers
- 2,500 people
- Sponsor
- IRCCS San Raffaele
Inclusion Body Myositis (IBM), Motor Neuron Disease, Amyotrophic Lateral Sclerosis
The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition
The aim of the study is to characterize 30 patients exhibiting muscular atrophy and weakness who require a muscle biopsy for diagnosis (suspected inclusion body myopathy vs atypical motor neuron disease), through an innovative…
- Trial name
- TDP-signatures (NCT07796776)
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- IRCCS San Raffaele
Pancreatic Cancer
Pancreatic Cancer Lifestyle Evolution And Resistance
Advanced PDAC patients undergo polychemotherapy, yet responses are highly variable. Transcriptome signatures are emerging as key predictors of treatment response. However, PDAC adapts across sites (primary vs.
- Trial name
- CLEAR (NCT07794969)
- Testing
- Endoscopic Ultrasound with FNA/FNB
- Volunteers
- 150 people
- Sponsor
- IRCCS San Raffaele
Spinal Cord Injuries
Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury
Interventional prospective longitudinal on the evaluation of spinal cord stimulation (SCS) assisted by motor rehabilitation training for restoring motor function in patients with spinal cord injury (SCI).
- Trial name
- NeuroSCS (NCT05926843)
- Testing
- Spinal cord stimulation surgery (device) and motor rehabilitation
- Where
- Italy
- Volunteers
- 10 people
- Sponsor
- IRCCS San Raffaele
Benign Gynecological Disease, Uterine Fibroids
Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological Surgery
This prospective observational registry aims to systematically collect preoperative, intraoperative, and postoperative clinical data from patients undergoing surgery for benign gynecological conditions.
- Conditions
- Benign Gynecological Disease, Uterine Fibroids, Endometriosis, Adenomyosis
- Trial name
- OPGYNBEN (NCT07772076)
- Testing
- Standard Surgical Procedures for Benign Gynecological Conditions
- Where
- Italy
- Volunteers
- 6,000 people
- Sponsor
- IRCCS San Raffaele
Pancreatic Diseases
Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
This prospective observational study aims to investigate pathogenic myelopoiesis in patients with pancreatic ductal adenocarcinoma (PDAC) and to characterize the systemic immune alterations associated with tumor-related…
- Trial name
- PaMPa (NCT07765316)
- Volunteers
- 100 people
- Sponsor
- IRCCS San Raffaele
Chronic Lymphocytic Leukemia (CLL), Splenic Marginal Zone Lymphoma
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies
Adult patients with chronic lymphocytic leukemia (CLL), splenic marginal-zone lymphoma (SMZL) and hairy cell leukemia (HCL) followed at participating clinical sites will be enrolled and undergo sampling of additional amount of…
- Conditions
- Chronic Lymphocytic Leukemia (CLL), Splenic Marginal Zone Lymphoma, Hairy Cell Leukemia (HCL)
- Trial name
- IMPACT (NCT07759661)
- Where
- Italy
- Volunteers
- 64 people
- Sponsor
- IRCCS San Raffaele
VEXAS
DECIPHERING AND TARGETING VEXAS
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome (1/4,000 males aged >50) is a paradigmatic age-onset acquired, severe, autoinflammatory hematological disease due to clonal dominance of hematopoietic…
- Trial name
- DTV (NCT07746986)
- Where
- Italy
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele
Chronic Lymphocytic Leukemia (CLL)
Targeting IRAK4 in Chronic Lymphocytic Leukemia
Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests.
- Trial name
- PS-CLL016 (NCT07741695)
- Testing
- Peripheral blood sample collection
- Volunteers
- 50 people
- Sponsor
- IRCCS San Raffaele
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies
This is a monocentric, no-profit, retrospective and prospective observational cohort study conducted at IRCCS Ospedale San Raffaele. The study does not entail any additional procedures or interventions for participants.
- Trial name
- HEAL-MD (NCT07745218)
- Where
- Italy
- Volunteers
- 25 people
- Sponsor
- IRCCS San Raffaele